Jeffrey D. Erb, has created a culture of innovation at HealixGlobal — status quo is not in our vocabulary. He constantly encourages his team to look for ways to adjust our thinking and that of our clients to break down barriers and expand the reach of our clients’ brands.
Jeff is changing healthcare media buying with the incorporation of psychological and behavioral data to improve targeting and engagement – something that has been elusive in this highly regulated industry. He is responsible for organizing this move to bring unprecedented levels of qualitative and quantitative analytics to the forefront of the creative planning process through the development of Healix’s proprietary analytics tool, DNA. DNA allows us to layer traditional qualitative marketing data with the psychology of human qualitative engagement and allow us to see not only the what, where, when and how people engage with a communication program, but also the “why” people engage the way they do — all anonymously and within HIPAA guidelines. This gives brands a tool to better understand how their messages are driving openness to recommendations and, ultimately, scripts.
Jeff was honored at the awards reception held October 9 at the 2018 DTC Forum on Social Media & Technology.
For a list of all honorees, click here.
MM&M recently sat down with Jeff Erb to discuss industry consolidation and how agencies need to adjust to meet the changing demand. See what Jeff had to say.
Even after the implosion of Outcome Health painted a shroud of distrust over the entire point of care media industry, the demand for in-office media solutions targeting both patients and physicians far exceeds the supply. Groups such as PoC3 have been established to help police ethical best practices and standards, and companies such as PlaceBridge have been launched to provide independent third-party auditing and verification for the media in-market, which will help bring back client confidence. However, while other well-established companies pride themselves in a reputable alternative solution, there remains a gap in the total inventory available to be able to reach the patient at the point of care…
In the lastest issue of PM36o, Jeffrey Erb, president of HealixGlobal, discusses the need for healthcare and pharmaceutical companies to take these solutions seriously, as they represent a growing patient engagement and distribution platform. Read the article here.
PM360 ELITE 100 recognizes individuals and teams in the healthcare and life sciences industries who are making the most impact. This year, two members of the Healix team were honored to be recognized.
Jeffrey Erb, president of Healix, was name a Transformational Leader. Jeff has fostered a strong corporate culture at Healix that emphasizes collaboration and innovation. In the short 2 years since Healix was formed, he has doubled the agency’s client listRead more about what makes Jeff stand out here.
Luigi Camacho, media planning supervisor, was named a Leader of the Future. “Luigi doesn’t over delegate and doesn’t micro-manage,” explains his manager, Scott Cofsky, vice president of Media Strategy. “He creates a balance that leads to an independent team. He teaches them so they can be successful in their roles and creates opportunities for the team to learn and grow in a supportive environment.” Luigi was also the first recipient of Healix’s ACE Award for Innovation. Read more about Luigi here.
You can see all the honorees on PM360’s website.
The MOMAs celebrate the brands and agencies delivering the best campaigns and strategies that are leading the way in mobile.
We are so proud to be a finalist with our client Merck Animal Health and partner Jun Group in The Drum MOMA Awards for Most Effective Mobile Advertising Campaign and Mobile Sales Promotion/Lead Generation/Direct Response Strategy!
We are looking forward to the award ceremony on May 17th in London to find out who the winners are. To see all the nominees or learn more about The Drum MOMA Awards, go to www.momas.co.uk.